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One important virulence factor of enterotoxigenic Escherichia coli is their ability to adhere via ﬁmbrial
adhesins to speciﬁc receptors located on the intestinal mucosa. Here, the potential glycosphingolipid
receptors of enterotoxigenic F6-ﬁmbriated E. coli were examined by binding of puriﬁed F6 ﬁmbriae, and
F6-expressing bacteria, to glycosphingolipids on thin-layer chromatograms. When intestinal mucosal
non-acid glycosphingolipids from single pigs were assayed for F6 binding capacity, a selective interaction
with two glycosphingolipids was observed. The binding-active glycosphingolipids were isolated and
characterized as lactotriaosylceramide (GlcNAcb3Galb4Glcb1Cer) and lactotetraosylceramide
(Galb3GlcNAcb3Galb4Glcb1Cer). Further binding assays using a panel of reference glycosphingolipids
showed a speciﬁc interaction between the F6 ﬁmbriae and a number of neolacto core chain
(Galb4GlcNAc) glycosphingolipids. In addition, an occasional binding of the F6 ﬁmbriae to sulfatide,
galactosylceramide, lactosylceramide with phytosphingosine and/or hydroxy fatty acids, iso-
globotriaosylceramide, gangliotriaosylceramide, and gangliotetraosylceramide was obtained. From the
results we conclude that lactotriaosylceramide and lactotetraosylceramide are major porcine intestinal
receptors for F6-ﬁmbriated E. coli.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Infection with F4 (K88)-, F5 (K99)-, F6 (987P)- and/or F18-
ﬁmbriated Escherichia coli is a common cause of diarrhea or
edema disease in young pigs, thereby leading to signiﬁcant eco-
nomic losses. The carbohydrate receptors involved in adherence of
most of these E. coli strains to the porcine intestinal epithelium
have been subjected to thorough investigations, leading to identi-
ﬁcation of carbohydrates involved in F4þ, F5þ and F18þ E. coli
adherence. Thus, F5þ E. coli was shown to adhere to NeuGc-GM3
[1,2], whereas F18þ E. coli have a speciﬁc binding to blood group
ABH determinants on type 1 core chains [3], and F4þ E. coli rec-
ognizes a more diverse set of carbohydrates on sphingolipid or
protein backbones [4e6].
The F6 ﬁmbriae are polymeric structures consisting of hundreds
of copies of FasA (major subunit), supplemented with the minorS. Teneberg).
Ltd. This is an open access article usubunits FasF and FasG. FasF is the linker between FasA and FasG,
and the adhesive subunit is FasG [7e10]. Different chaperone pro-
teins are used for various F6 subunits, with FasB being the peri-
plasmic chaperone for FasA, and FasC being the chaperone for the
adhesin FasG [11]. FasD was characterized as the usher involved in
transport of the ﬁmbrial subunits across the outer membrane and
FasE is a third chaperone-like protein [12], and FasH activates
transcription of the structural subunit FasA [13].
Earlier studies have shown that the FasG adhesin recognizes a
speciﬁc set of protein receptors with sizes of 33e39 kDa,17 kDa and
14 kDa [9]. The 33e39 kDa proteins were identiﬁed as histone H1
proteins, which are recognized by F6 ﬁmbriae in a carbohydrate-
independent manner [14]. By immunohistochemistry and elec-
tron microscopy these histone H1 proteins were visualized on the
microvilli of neonatal piglet intestinal epithelium, and it was sug-
gested that the histone H1 proteins might stabilize the interaction
between F6 ﬁmbriae and cell membrane compounds, by binding
simultaneously to the membrane and the F6 ﬁmbriae.
Binding of F6 ﬁmbriae to the two major glycosphingolipids of
porcine intestinal epithelium, sulfatide (SO3-3Galb1Cer) andnder the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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has been demonstrated that lysine-117 of the FasG subunit is
involved in the interaction with sulfatide [16]. Binding of F6
ﬁmbriated E. coli to gangliotetraosylceramide (Galb3GalNAcb4-
Galb4Glcb1Cer), lactosylceramide (Galb4Glcb1Cer), sulfatide, gan-
gliotriaosylceramide (GalNAcb4Galb4Glcb1Cer), and
galactosylceramide has also been reported [17,18].
During our studies of carbohydrate recognition by ﬁmbriae of
porcine ETEC we also examined the potential role of carbohydrates
as adhesion receptors for F6 ﬁmbriated E. coli, by binding of F6
ﬁmbriae to an extensive panel of glycosphingolipids. Thereby a
speciﬁc interaction between F6-expressing bacteria, and puriﬁed F6
ﬁmbriae, and a number of neolacto core chain (Galb4GlcNAc) gly-
cosphingolipids was detected, in addition to the previously
described binding to sulfatide and galactosylceramide. Two minor
glycosphingolipids recognized by F6 ﬁmbriae were isolated from
piglet intestinal mucosa, and characterized by mass spectrometry
and proton NMR as lactotriaosylceramide (GlcNAcb3-
Galb4Glcb1Cer) and lactotetraosylceramide
(Galb3GlcNAcb3Galb4Glcb1Cer).2. Materials and methods
2.1. Bacterial strains, culture conditions and labeling
The prototype F6-positive E. coli strain 987 (serotype
O9:K103:NM, F6þ, STaþ, STbþ) was grown in Mueller Hinton broth
(Oxoid, Basingstoke, Hampshire, England) [19].
For metabolic labeling, the culture medium was supplemented
with 10 ml 35S-methionine (400 mCi; Amersham Pharmacia
Biotech) per 10 ml. Bacteria were harvested by centrifugation,
washed three times in phosphate-buffered saline, pH 7.4 (PBS),
and resuspended in PBS containing 2% (w/v) bovine serum albu-
min, 0.1% (w/v) NaN3 and 0.1% (w/v) Tween 20 (BSA/PBS/TWEEN)
to a bacterial density of 1  108 colony forming units/ml. The
speciﬁc activity of bacterial suspensions was approximately 1 cpm
per 100 bacteria.2.2. Puriﬁcation of F6 ﬁmbriae
E. coli strain 987 was cultured statically in Mueller Hinton broth
at 37 C during 6 days. After growing these bacteria, slide aggluti-
nation with an F6-speciﬁc monoclonal antibody (CVI Wageningen,
Lelystad, The Netherlands) was performed to conﬁrm the presence
of F6 ﬁmbriae. Next, the bacteria were harvested by centrifugation
at 2750 g for 35 min, and suspended in phosphate-buffered saline
(PBS, pH 7.4). Subsequently, the bacteria were washed with ice cold
PBS and the bacterial pellet was mixed using an Ultra Turrax for
20 min. The mixed bacterial suspensionwas then centrifuged twice
at 12,500 g to separate the bacterial cell debris from the ﬁmbrial
solution. Thereafter, the bacterial pellet was discarded and the
ﬁmbriae were precipitated with 60% ammonium sulfate at 4 C
overnight. After centrifugation at 1450 g for 30 min, the precipi-
tated ﬁmbriae are dissolved in PBS and dialyzed against PBS over-
night at 4 C.2.3. 125I-labeling
Aliquots of 100 mg of ﬁmbrial protein were labeled with 125I,
using Na125I (100 mCi/ml; Amersham Pharmacia Biotech, Little
Chalfont, U.K.), according to the IODO-GEN protocol of the manu-
facturer (Pierce, Rockford, IL), giving approximately 2  103 cpm/mg
protein.2.4. Reference glycosphingolipids
Total acid and non-acid glycosphingolipid fractions were iso-
lated as described [20]. Individual glycosphingolipids were isolated
by repeated chromatography on silicic acid columns and by HPLC,
and identiﬁed by mass spectrometry [21,22], and 1H NMR spec-
troscopy [23].
2.5. Thin-layer chromatography
Thin-layer chromatography was done on aluminum- or glass-
backed silica gel 60 high performance thin-layer chromatography
plates (Merck, Darmstadt, Germany). Glycosphingolipid mixtures
(40 mg) or pure glycosphingolipids (4 mg) were applied to the plates,
and eluted with chloroform/methanol/water (60:35:8, by volume)
as solvent system. Chemical detection was done with anisaldehyde
[24].
2.6. Chromatogram binding assay
Binding of radiolabeled F6 ﬁmbriae and F6-ﬁmbriated bacteria
to glycosphingolipids on thin-layer chromatograms was done as
described previously [3,6]. Dried chromatograms were dipped in
diethylether/n-hexane (1:5 v/v) containing 0.5% (w/v) poly-
isobutylmethacrylate for 1 min. To diminish background binding
the chromatograms were blocked with 2% (w/v) bovine serum al-
bumin, 0.1% (w/v) NaN3 and 0.1% (w/v) Tween 20 (BSA/PBS/
TWEEN) for 2 h at room temperature. Then the plates were incu-
bated with 125I-labeled ﬁmbriae (1e5  106 cpm/ml) or 35S-labeled
bacteria (1e5  106 cpm/ml) diluted in BSA/PBS/TWEEN for
another 2 h at room temperature. After washing six times with PBS,
and drying, the thin-layer plates were autoradiographed for 12 h
using XAR-5 X-ray ﬁlms (Eastman Kodak, Rochester, NY).
Chromatogram binding assays with monoclonal antibodies
directed against the blood group A determinant (Dakopatts a/s,
Glostrup, Denmark) were done as described [25], using 125I-labeled
anti-mouse antibodies for detection.
2.7. Isolation of F6 ﬁmbriae binding non-acid tri- and tetra-
glycosylceramides from piglet small intestinal mucosa
Non-acid glycosphingolipids were isolated from mucosal
scrapings from one blood group O and one blood group A six weeks
old piglet small intestines as described [20]. Brieﬂy, the mucosal
scrapings were lyophilized, and then extracted in two steps in a
Soxhlet apparatus with chloroform and methanol (2:1 and 1:9, by
volume, respectively). The material obtained was subjected to mild
alkaline hydrolysis and dialysis, followed by separation on a silicic
acid column. Acid and non-acid glycosphingolipid fractions were
obtained by chromatography on a DEAE-cellulose column. In order
to separate the non-acid glycolipids from alkali-stable phospho-
lipids, this fractionwas acetylated and separated on a second silicic
acid column, followed by deacetylation and dialysis. Final puriﬁ-
cations were done by chromatographies on DEAE-cellulose and
silicic acid columns. Thereby, 180 mg total non-acid glyco-
sphingolipids were obtained from 24 g dry weight blood group O
piglet small intestinal mucosa, while 60 mg was obtained in the
case of the blood group A piglet small intestinal mucosa (dry
weight 21 g).
The F6 binding tetraglycosylceramide was isolated from the
non-acid fraction of the blood group A piglet small intestinal mu-
cosa. Here, 40 mg of the total non-acid glycosphingolipid fraction
was ﬁrst separated on a silicic acid column eluted with increasing
volumes of methanol in chloroform. Thereby one fraction con-
taining monoglycosylceramides and one fraction containing
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was obtained. The latter fraction (17.5 mg) was separated on an
Iatrobeads (Iatrobeads 6RS-8060; Iatron Laboratories, Tokyo) col-
umn (2 g) eluted with 20  1 ml chloroform/methanol/water
60:35:8 (by volume). Throughout the separation procedures ali-
quots of the fractions obtained were analyzed by thin-layer chro-
matography, and fractions that were colored green by anisaldehyde
were tested for binding of F6 ﬁmbriae using the chromatogram
binding assay.
The F6 binding fractions were pooled, and further separations
were achieved by repeating the Iatrobeads column chromatog-
raphy two times. The ﬁrst column (2 g) was eluted with 20 0.5 ml
chloroform/methanol/water 60:35:8 (by volume), while the second
column (2 g) was eluted with 30  0.5 ml chloroform/methanol/
water 65:25:4 (by volume). The F6 binding compound migrating in
the tetraglycosylceramide region eluted in fraction 28, and this
fraction was designated fraction A-tetra (0.5 mg), and used for
structural characterization.
The same strategy was used for isolating the F6 binding trigly-
cosylceramide from the non-acid fraction of the blood group O
piglet small intestinal mucosa. Thus, 160 mg of the total non-acid
glycosphingolipid fraction was ﬁrst separated on a silicic acid col-
umn eluted with increasing volumes of methanol in chloroform.
Thereafter, the triglycosylceramide recognized by the F6 ﬁmbriae
was isolated by repeated chromatographies on Iatrobeads columns,
and ﬁnally, a fraction containing the F6 ﬁmbriae binding compound
was obtained. This fraction, designated fraction O-tri (0.7 mg), was
used for structural characterization.
2.8. ESI/MS and ESI/MS/MS of native glycosphingolipids
The glycosphingolipids (dissolved in methanol/acetonitrile
75:25, by volume) were separated on a 200  0.150 mm column,
packed in-house with 5 mm polyamine II particles (YMC Europe
GMBH, Dinslaken, Germany), and eluted with a water gradient (A:
100% acetonitrile; B: 10 mM ammonium bicarbonate). Samples
were analyzed on an LTQ linear quadrupole ion trap mass spec-
trometer (Thermo Electron) by LC-ESI/MS at3.5 kV. Full-scan (m/z
500e1800, 2 microscans, maximum 100ms, target value of 30,000)
was performed, followed by data dependent MS2 scans (2 micro-
scans, maximum 100 ms, target value of 10,000) with normalized
collision energy of 35%, an isolation window of 2.5 units, an acti-
vation q ¼ 0.25, and an activation time of 30 ms.
2.9. Endoglycoceramidase digestion and LC/MS
Endoglycoceramidase II from Rhodococcus spp. (Takara Bio
Europe S.A., Gennevilliers, France) was used for hydrolysis of gly-
cosphingolipids. Brieﬂy, 50 mg of the F6 binding non-acid glyco-
sphingolipid fractions from piglet small intestine (fractions O-tri
and A-tetra) were resuspended in 100 ml 0.05 M sodium acetate
buffer, pH 5.0, containing 120 mg sodium cholate, and sonicated
brieﬂy. Thereafter, 1 mU of endoglycoceramidase II was added and
the mixture was incubated at 37 C for 48 h. The reaction was
stopped by addition of chloroform/methanol/water to the ﬁnal
proportions 8:4:3 (by volume). The oligosaccharide-containing
upper phase thus obtained was separated from detergent on a
Sep-Pak QMA cartridge (Waters, Milford, MA). The eluants con-
taining the oligosaccharides were dried under nitrogen and under
vacuum.
The glycosphingolipid-derived oligosaccharides were analyzed
by capillary-LC/MS and MS/MS as described [22]. In brief, the oli-
gosaccharides were separated on a column (200  0.180 mm)
packed in-house with 5 mm porous graphite particles (Hypercarb,
Thermo Scientiﬁc), and eluted with an acetonitrile gradient (A:8 mM ammonium bicarbonate; B: 100% acetonitrile). The saccha-
rides were analyzed in the negative ion mode on an LTQ linear
quadrupole ion trap mass spectrometer (Thermo Electron, San Jose,
CA).
3. Results
3.1. Binding of F6 ﬁmbriae and F6 ﬁmbriated E. coli to
glycosphingolipid mixtures
In order to expose the F6 ﬁmbriae to a large number of variant
carbohydrate structures, mixtures of glycosphingolipids separated
on thin-layer plates were used in the initial screening for carbo-
hydrate recognition by the F6 ﬁmbriae and F6 ﬁmbriated bacteria.
Among the total acid and non-acid fractions coming from different
sources (more than 30 fractions tested), the F6 ﬁmbriae and the F6
ﬁmbriated bacteria bound only to few glycosphingolipids (Fig. 1).
Thus, there was a distinct binding of both the ﬁmbriae and the
bacterial cells to a number of compounds in the non-acid fractions
of horse erythrocytes (Fig. 1(B), lane 1), bovine erythrocytes
(Fig. 1(B), lane 4), rabbit erythrocytes (Fig. 1(B), lane 5; Fig. 1(D) and
(E), lane 2) and rabbit thymus (Fig. 1(B), lane 6; Fig. 1(D) and (E),
lane 1). This ﬁnding suggested a recognition of neolacto-containing
glycosphingolipids, since the major glycosphingolipids of several of
these fractions are based on neolacto core chains [26e30].
3.2. Binding of F6 ﬁmbriae non-acid glycosphingolipid mixtures of
piglet small intestinal mucosa
Two different binding patterns were observed upon binding of
F6 ﬁmbriae to non-acid glycosphingolipids of piglet intestinal
mucosa. The ﬁrst pattern was obtained with the glycosphingolipid
mixture from a blood group O pig where the F6 ﬁmbriae bound to a
compound migrating in the triglycosylceramide region (Fig. 2(B),
lane 2). The second pattern, obtained with the glycosphingolipid
mixture from a blood group A pig, was binding of the ﬁmbriae to
two compounds migrating as tri- and tetra-glycosylceramides,
respectively (Fig. 2(B), lane 3).
3.3. Isolation and characterization of the F6 binding
glycosphingolipids from piglet small intestinal mucosa
3.3.1. F6 binding triglycosylceramide
The triglycosylceramide recognized by the F6 ﬁmbriae was
isolated from the non-acid glycosphingolipid fraction of the blood
group O piglet intestinal mucosa by chromatographies on silicic
acid and Iatrobeads columns, and the fractions obtained were
tested for F6 binding activity using 125I-labeled F6 ﬁmbriae. After
several chromatographic steps 0.7 mg of a triglycosylceramide
fraction containing the F6-binding glycosphingolipid was obtained
(designated fraction O-tri (Fig. 3(A) and (B), lane 3)).
Structural characterization of fraction O-tri demonstrated that it
contained two glycosphingolipids, globotriaosylceramide (Gal-
a4Galb4Glcb1Cer) and lactotriaosylceramide (GlcNAcb3-
Galb4Glcb1Cer). This conclusion is based on the following
observations:
I) The binding-active compound migrated in the triglyco-
sylceramide region on thin-layer chromatograms (Fig. 2, lane
2 and 3; Fig. 3(A) and (B), lane 3).
II) By LC/MS analysis of the saccharides obtained by hydrolysis
of fraction O-tri with Rhodococcus endoglycoceramidase, two
[MH] ions were observed at m/z 503 (retention time
17.3e18.1 min) and at m/z 544 (retention time
20.1e20.7 min), respectively (Fig. 3(C)).
Fig. 1. Binding of F6 ﬁmbriae and F6-ﬁmbriated Escherichia coli to glycosphingolipid mixtures. Chemical detection by anisaldehyde (A and C), and autoradiograms obtained by
binding of 125I-labeled F6 ﬁmbriae (B and E), and 35S-labeled F6-expressing E. coli (D). The glycosphingolipids were separated on aluminum-backed silica gel plates, using chlo-
roform/methanol/water 60:35:8 (by volume) as solvent system, and the binding assays were performed as described under “Materials and Methods”. Autoradiography was for 12 h.
The lanes on chart A and B were: Lane 1, non-acid glycosphingolipids of horse erythrocytes, 40 mg; Lane 2, non-acid glycosphingolipids of cat erythrocytes, 40 mg; Lane 3, non-acid
glycosphingolipids of porcine erythrocytes, 40 mg; Lane 4, non-acid glycosphingolipids of bovine erythrocytes, 40 mg; Lane 5, non-acid glycosphingolipids of rabbit erythrocytes,
40 mg; Lane 6, non-acid glycosphingolipids of rabbit thymus, 40 mg; Lane 7, acid glycosphingolipids of rabbit thymus, 40 mg. The lanes on chart CeE were: Lane 1, non-acid gly-
cosphingolipids of rabbit thymus, 40 mg; Lane 2, non-acid glycosphingolipids of rabbit erythrocytes, 40 mg; Lane 3, non-acid glycosphingolipids of human gastric cancer, 20 mg.
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prominent C-type fragment ions (C1 at m/z 179 and C2 at m/z 341)
identifying a triglycosylceramide with HexeHexeHex sequence
(Fig. 3(D)). There was also a 0.2A2 fragment ion at m/z 281Fig. 2. Binding of F6 ﬁmbriae to non-acid glycosphingolipids of piglet intestinal mu-
cosa. Chemical detection by anisaldehyde (A), and autoradiogram obtained by binding
of 125I-labeled F6 ﬁmbriae (B). The glycosphingolipids were separated on aluminum-
backed silica gel plates, using chloroform/methanol/water 60:35:8 (by volume) as
solvent system, and the binding assays were performed as described under “Materials
and Methods”. Autoradiography was for 12 h. The lanes were: Lane 1, non-acid gly-
cosphingolipids of rabbit thymus, 40 mg; Lane 2, non-acid glycosphingolipids of blood
group O piglet intestinal mucosa, 40 mg; Lane 3, non-acid glycosphingolipids of blood
group A piglet intestinal mucosa, 40 mg; Lane 4, acid glycosphingolipids of blood group
A piglet intestinal mucosa, 40 mg. The Roman numbers to the left of panel A denotes
the approximate numbers of carbohydrates in the non-acid glycosphingolipid fractions
in lanes 1e3.demonstrating an internal hexose substituted on C-4 as in Gal-
a4Galb4Glc (globotriaose) [22].
MS2 of the ion at m/z 544 gave C-type fragment ions at m/z 220
(C1) and atm/z 382 (C2), identifying a HexNAceHexeHex sequence
(Fig. 3(E)). No 0,2A2 fragment ion at m/z 322 was found, indicating
that the penultimate Hex was 3-substituted. Taken together these
spectral features tentatively identiﬁed a lacto trisaccharide
(GlcNAcb3Galb4Glc).
3.3.2. F6 binding tetraglycosylceramide
The binding-active tetraglycosylceramide was isolated from the
non-acid glycosphingolipid fraction of the blood group A piglet
intestinal mucosa by chromatography on silicic acid and Iatrobeads
columns, and the preparative procedure was monitored by binding
of radiolabeled F6 ﬁmbriae on thin-layer chromatograms. Finally,
0.5 mg of an F6 binding tetraglycosylceramide fraction was ob-
tained (denoted fraction A-tetra).
Characterization of fraction A-tetra identiﬁed lactote-
traosylceramide (Galb3GlcNAcb3Galb4Glcb1Cer) and the A type 1
hexaosylceramide (GalNAca3(Fuca2)Galb3GlcNAcb3-
Galb4Glcb1Cer). This conclusion was based on the following
properties:
I) On thin-layer chromatograms the binding-active glyco-
sphingolipid migrated as a distinct band in tetraglyco-
sylceramide region (Fig. 2(B), lane 3).
II) The base peak chromatogram from ESI/MS of the native
fraction A-tetra had one [MH] ion at m/z 1241 and one
[MH] ion at m/z 1574 (data not shown). These ions indi-
cated one glycosphingolipid with one HexNAc and three Hex
Fig. 3. Characterization of the F6 ﬁmbriae binding triglycosylceramide of piglet intestinal mucosa. Chemical detection by anisaldehyde (A), and autoradiogram obtained by binding
of 125I-labeled F6 ﬁmbriae (B). The glycosphingolipids were separated on aluminum-backed silica gel plates, using chloroform/methanol/water 60:35:8 (by volume) as solvent
system, and the binding assays were performed as described under “Materials and Methods”. Autoradiography was for 12 h. The lanes were: Lane 1, non-acid glycosphingolipids of
blood group A piglet intestinal mucosa, 40 mg; Lane 2, non-acid glycosphingolipids of blood group O piglet intestinal mucosa, 40 mg; Lane 3, Fraction O-tri isolated from blood group
O piglet intestinal mucosa, 4 mg. (C) Base peak chromatogram from LC-ESI/MS of the oligosaccharides obtained by digestion with Rhodococcus endoglycoceramidase II of the F6-
binding glycosphingolipid fraction O-tri from blood group O piglet intestinal mucosa. (D) MS2 spectrum of the ion at m/z 503 (retention time 17.3 min). (E) MS2 spectrum of the ion
at m/z 544 (retention time 20.7 min). The interpretation formulas show the deduced carbohydrate sequences.
Fig. 4. Characterization of the F6 ﬁmbriae binding tetraglycosylceramide of porcine intestinal mucosa. (A) Base peak chromatogram from LC-ESI/MS of the oligosaccharides ob-
tained by digestion with Rhodococcus endoglycoceramidase II of the F6-binding glycosphingolipid fraction A-tetra. (B) MS2 spectrum of the ion at m/z 1055 (retention time
19.8e20.3 min). (C) MS2 spectrum of the ion at m/z 706 (retention time 23.0e23.6 min). (D) Interpretation formulas showing the deduced carbohydrate sequences.
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Fig. 5. Binding of F6 ﬁmbriae to reference glycosphingolipids. Chemical detection by
anisaldehyde (A), and autoradiogram obtained by binding of 125I-labeled F6 ﬁmbriae
(B). The glycosphingolipids were separated on aluminum-backed silica gel plates, using
chloroform/methanol/water 60:35:8 (by volume) as solvent system, and the binding
assay was performed as described under “Materials and Methods”. Autoradiography
was for 12 h. The lanes were: Lane 1, neolactotetraosylceramide (Galb4GlcNAcb3-
Galb4Glcb1Cer) of human neutrophils, 4 mg; Lane 2, GM3 ganglioside (Neu-
Aca3Galb4Glcb1Cer) of human brain, 4 mg; Lane 3, blood group H type 2
pentaglycosylceramide (Fuca2Galb4GlcNAcb3Galb4Glcb1Cer) of human erythrocytes,
4 mg; Lane 4, blood group B type 2 hexaglycosylceramide (Gala3(Fuca2)Galb4Glc-
NAcb3Galb4Glcb1Cer) of human erythrocytes, 4 mg; Lane 5, blood group A type 1
hexaglycosylceramide (GalNAca3(Fuca2)Galb3GlcNAcb3Galb4Glcb1Cer) of human
meconium, 4 mg; Lane 6, B5 pentaglycosylceramide (Gal-
a3Galb4GlcNAcb3Galb4Glcb1Cer) of rabbit erythrocytes, 4 mg.
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one Fuc, three HexNAc and three Hex and d18:1-16:0 cer-
amide, respectively.
III) The base peak chromatogram from LC/MS of the saccharides
obtained by hydrolysis of fraction A-tetra with Rhodococcus
endoglycoceramidase had two [MH] ions at m/z 1055
(retention time 19.8e20.3 min) and at m/z 706 (retention
time 23.0e23.6 min) (Fig. 4(A)).
IV) The MS2 spectrum of the [MH] ion at m/z 1055 was weak
(Fig. 4(B)). However, the series of C ions (C2a atm/z 528, C3a at
m/z 731, C4a at m/z 893) indicated an oligosaccharide with
HexNAc(eFuce)HexeHexNAceHexeHex sequence. The
absence of a 0,2A3 ion at m/z 630 suggested that the
internal HexNAcwas substituted at C3, i.e. a type 1 core chain
[22]. Thus, a hexasaccharide with HexNAce(Fuc)
HexeHexNAceHexeHex sequence and an internal
HexNAc substituted at C-3 was indicated, most likely a
blood group A type 1 hexasaccharide (GalNAca3(Fuca2)
Galb3GlcNAcb3Galb4Glc).Fig. 6. Binding of F6 ﬁmbriae to reference glycosphingolipids. Chemical detection by anisald
glycosphingolipids were separated on aluminum-backed silica gel plates, using chloroform
performed as described under “Materials and Methods”. Autoradiography was for 12 h.
Galb4Glcb1Cer) of dog intestine, 4 mg; Lane 2, globotetraosylceramide of (GalNAcb3Gala4G
Galb4Glcb1Cer) of guinea pig erythrocytes, 4 mg; Lane 4, lactosylceramide (Galb4Glcb1Cer)
hexaglycosylceramide (Gala3(Fuca2)Galb4GlcNAcb3Galb4Glcb1Cer) of human erythrocytes,
GlcNAcb3Galb4Glcb1Cer) of monkey intestine, 1 mg; Lane 7, Lea pentaglycosylceramide
aglycosylceramide (Fuca2Galb3(Fuca4)GlcNAcb3Galb4Glcb1Cer) of human meconium, 4 mgA fragment ion at m/z 202 was present in the MS2 spectrum of
the ion at m/z 706 (Fig. 4(C)). This fragment ion is obtained by
C2eZ2 double cleavage (D1e2), and is characteristic for an internal 3-
linked GlcNAc [31]. The prominent 0,2A4 ion at m/z 646, and the
0,2A4-H2O ion at m/z 628, were derived from the lactose unit at the
reducing end. Taken together with the C2 ion atm/z 382, and the C3
ion at m/z 544, and the absence of a 0,2A2 ion at m/z 281 and 0,2A3
ion at m/z 484, this tentatively identiﬁed a
Hexe3HexNAce3Hexe4Hex saccharide, most likely a lacto tetra-
saccharide (Galb3GlcNAcb3Galb4Glc).
The two F6 binding fractions from piglet intestine both con-
tained two compounds, globo- and lacto-triaosylceramide in the
case of fraction O-tri, while fraction A-tetra had lactotetraosylcer-
amide and blood group A type 1 hexaglycosylceramide. However,
globotriaosylceramide and the A type 1 hexaosylceramide were
also found in the preceding and later-eluting fractions from the
ﬁnal Iatrobeads columns that were devoid of F6 binding activity
and, no binding of the F6 ﬁmbriae to reference globotriaosylcer-
amide from human erythrocytes or reference the A type 1 hex-
aosylceramide from human small intestine was obtained (see
below). Thus, lactotriaosylceramide and lactotetraosylceramide
were the F6 ﬁmbriae binding glycosphingolipids from piglet small
intestinal mucosa.3.4. Binding of F6 ﬁmbriae to reference glycosphingolipids
Next the binding of the F6 ﬁmbriae to a number of pure glyco-
sphingolipids at deﬁned concentrations was tested in the chro-
matogram binding assay. The results are exempliﬁed in Figs. 5e7,
and summarized in Table 1. Thus, in addition to lactotriaosylcer-
amide and lactotetraosylceramide of porcine small intestinal
epithelium, the F6 ﬁmbriae bound to galactosylceramide, sulfatide,
lactosylceramide with phytosphingosine and/or hydroxy fatty acids
(Galb4Glcb1Cer; Fig. 6, lane 4, Fig. 7, lane 3), iso-
globotriaosylceramide (Gala3Galb4Glcb1Cer; Fig. 7, lane 5), gan-
gliotriaosylceramide (GalNAcb4Galb4Glcb1Cer Fig. 7, lane 8),
gangliotetraosylceramide (Galb3GalNAcb4Galb4Glcb1Cer), neo-
lactotetraosylceramide (Galb4GlcNAcb3Galb4Glcb1Cer; Fig. 5, lane
1), neolactohexaosylceramide (Galb4GlcNAcb3Galb4GlcNAcb3-
Galb4Glcb1Cer), and neolactooctaosylceramide (Galb4GlcNAcb3-
Galb4GlcNAcb3Galb4GlcNAcb3Galb4Glcb1Cer). Apart from the
lactosylceramide binding, which required phytosphingosine and
hydroxy fatty acids, there was no apparent dependence on a certain
ceramide composition for the binding to occur.ehyde (A), and autoradiogram obtained by binding of 125I-labeled F6 ﬁmbriae (B). The
/methanol/water 60:35:8 (by volume) as solvent system, and the binding assay was
The lanes were: Lane 1, Forssman pentaglycosylceramide (GalNAca3GalNAcb3Gala4-
alb4Glcb1Cer) human erythrocytes, 4 mg; Lane 3, gangliotriaosylceramide (GalNAcb4-
with t18:0-h16:0-h24:0 ceramide of dog intestine, 4 mg; Lane 5, blood group B type 2
4 mg; Lane 6, blood group B type 1 heptaglycosylceramide (Gala3(Fuca2)Galb3(Fuca4)
(Galb3(Fuca4)GlcNAcb3Galb4Glcb1Cer) of human intestine, 4 mg; Lane 8, Leb hex-
.
Fig. 7. Binding of F6 ﬁmbriae to reference glycosphingolipids. Chemical detection by anisaldehyde (A), and autoradiogram obtained by binding of 125I-labeled F6 ﬁmbriae (B). The
glycosphingolipids were separated on aluminum-backed silica gel plates, using chloroform/methanol/water 60:35:8 (by volume) as solvent system, and the binding assay was
performed as described under “Materials and Methods”. Autoradiography was for 12 h. The lanes were: Lane 1, galactosylceramide (Galb1Cer) from SigmaeAldrich with d18:1-
h18:0-h24:0 ceramide, 4 mg; Lane 2, sulfatide (SO3-3Galb1Cer) of human intestine with t18:0-h24:0 ceramide, 4 mg; Lane 3, lactosylceramide (Galb4Glcb1Cer) of dog intestine
with t18:0-h16:0-h24:0 ceramide, 4 mg; Lane 4, lactosylceramide (Galb4Glcb1Cer) of human neutrophils with d18:1-16:0-24:1 ceramide, 4 mg; Lane 5, isoglobotriaosylceramide
(Gala3Galb4Glcb1Cer) of cat intestine with t18:0-h22:0 and h24:0 ceramide, 4 mg; Lane 6, globotriaosylceramide (Gala4Galb4Glcb1Cer) of human erythrocytes with d18:1-16:0-
24:1 ceramide, 4 mg; Lane 7, lactotriaosylceramide (GlcNAcb3Galb4Glcb1Cer) of pig intestine with d18:1-h16:0 ceramide, 4 mg; Lane 8, gangliotriaosylceramide (GalNAcb4-
Galb4Glcb1Cer) of guinea pig erythrocytes with d18:1-16:0 and 24:0 ceramide, 4 mg.
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lactotriaosylceramide, lactotetraosylceramide, and the neolacto gly-
cosphingolipids was highly reproducible, binding to galactosylcer-
amide, sulfatide, lactosylceramide, isoglobotriaosylceramide,Table 1
Binding of 125I-labeled F6 ﬁmbriae to glycosphingolipids on thin-layer chromatograms.
No. Trivial name Structure
Simple compounds
1. Galactosylceramide Galb1Cer
2. Glucosylceramide Glcb1Cer
3. Sulfatide SO3-3Galb1Cer
4. LacCer (d18:1-16:0-24:0)b Galb4Glcb1Cer
5. LacCer (t18:0-h16:0-h24:0) Galb4Glcb1Cer
6. Isoglobotri Gala3Galb4Glcb1Cer
7. Globotri Gala4Galb4Glcb1Cer
8. Lactotri GlcNAcb3Galb4Glcb1Cer
Ganglioseries
9. Gangliotri GalNAcb4Galb4Glcb1Cer
10. Gangliotetra Galb3GalNAcb4Galb4Glcb1Cer
Neolactoseries
11. Neolactotetra Galb4GlcNAcb3Galb4Glcb1Cer
12. H5 type 2 Fuca2Galb4GlcNAcb3Galb4Glcb1Cer
13. Lex-5 Galb4(Fuca3)GlcNAcb3Galb4Glcb1Cer
14. B5 Gala3Galb4GlcNAcb3Galb4Glcb1Cer
15. B6 type 2 Gala3(Fuca2)Galb4GlcNAcb3Galb4Glcb1
16. A7 type 2 GalNAca3(Fuca2)Galb4(Fuca3)GlcNAcb3
17. B7 type 2 Gala3(Fuca2)Galb4(Fuca3)GlcNAcb3Galb
18. Neolactohexa (linear) Galb4GlcNAcb3Galb4GlcNAcb3Galb4Glcb
19. Neolactohexa (branched) Galb4GlcNAcb6(Galb4GlcNAcb3)Galb4Gl
20. Neolactoocta Galb4GlcNAcb3Galb4GlcNAcb3Galb4GlcN
Lactoseries
21. Lactotetra Galb3GlcNAcb3Galb4Glcb1Cer
22. Leb-6 Fuca2Galb3(Fuca4)GlcNAcb3Galb4Glcb1
23. A6 type 1 GalNAca3(Fuca2)Galb3GlcNAcb3Galb4G
24. A7 type 1 GalNAca3(Fuca2)Galb3(Fuca4)GlcNAcb3
Globoseries
25. Globotetra GalNAcb3Gala4Galb4Glcb1Cer
26. Forssman GalNAca3GalNAcb3Gala4Galb4Glcb1Cer
Gangliosides
27. GM3 NeuAca3Galb4Glcb1Cer
28. NeuAca3neolactotetra NeuAca3Galb4GlcNAcb3Galb4Glcb1Cer
29. NeuGca3neolactohexa NeuGca3Galb4GlcNAcb3Galb4GlcNAcb3
a Binding is deﬁned as follows:þþþ denotes a binding when 1 mg of the glycosphingoli
4 mg, while  denotes no binding even at 4 mg.
b In the shorthand nomenclature for fatty acids and bases, the number before the col
number of double bonds in the molecule. Fatty acids with a 2-hydroxy group are denote
dihydroxy and t trihydroxy. Thus d18:1 designates sphingosine (1,3-dihydroxy-2-aminogangliotriaosylceramide and gangliotetraosylceramide was only oc-
casionally obtained. This is exempliﬁed by gangliotriaosylceramide,
which is non-binding in Fig. 6 (lane 3), but recognized by the F6
ﬁmbriae in Fig. 7 (lane 8).Bindinga Source
þ SigmaeAldrich
 Porcine kidney
þ Pig intestine
 Human granulocytes
þ Dog intestine
þ Dog intestine
 Human erythrocytes
þþþ Piglet intestine
þ Guinea pig intestine
þ Mouse intestine
þþþ Human granulocytes
 Human erythrocytes
 Dog intestine
 Rabbit erythrocytes
Cer  Human erythrocytes
Galb4Glcb1Cer  Human erythrocytes
4Glcb1Cer  Human erythrocytes
1Cer þþþ Rabbit thymus
cb1Cer  Bovine buttermilk
Acb3Galb4Glcb1Cer þþþ Rabbit thymus
þþþ Piglet intestine
Cer  Human meconium
lcb1Cer  Human intestine
Galb4Glcb1Cer  Human meconium
 Human erythrocytes
 Dog intestine
 Human brain
 Human erythrocytes
Galb4Glcb1Cer  Rabbit thymus
pid was applied on the thin-layer chromatogram,þ denotes an occasional binding at
on refers to the carbon chain length and the number after the colon gives the total
d by the preﬁx h before the abbreviation e.g. h16:0. For long chain bases, d denotes
octadecene) and t18:0 phytosphingosine (1,3,4-trihydroxy-2-aminooctadecene).
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chromatogram binding assay (Table 1). Furthermore, all binding
assays in this study were done with both 125I-labeled F6-ﬁmbriae
and with 35S-labeled F6-ﬁmbriated E. coli. The F6 ﬁmbriae and
the F6-ﬁmbriated bacteria gave identical binding patterns,
although a high background binding often was obtained when
using bacterial cells.Fig. 8. Comparison of non-acid glycosphingolipids of newborn and adult pig small
intestinal mucosa. Chemical detection by anisaldehyde (A), and autoradiograms ob-
tained by binding of monoclonal antibodies directed against the blood group A
determinant (B), and 125I-labeled F6 ﬁmbriae (C). The glycosphingolipids were sepa-
rated on aluminum-backed silica gel plates, using chloroform/methanol/water 60:35:8
(by volume) as solvent system, and the binding assays were performed as described
under “Materials and Methods”. Autoradiography was for 12 h. Lane 1, non-acid gly-
cosphingolipids of the small intestinal mucosa of a three day old pig, 40 mg; Lane 2,
non-acid glycosphingolipids of the small intestinal mucosa of an adult pig, 40 mg. The
Roman numbers to the left of the chromatogram in (A) indicate the approximate
number of carbohydrate units in the bands.3.5. Comparison of non-acid glycosphingolipids of newborn and
adult pig small intestinal mucosa
The amount of the ganglioside NeuGc-GM3, recognized by F5-
(K99-) ﬁmbriated E. coli, in the porcine small intestine decreases as
the age of the pig increases [2]. Here the non-acid glyco-
sphingolipids from the small intestinal mucosa of a three day old
piglet and an adult pig were compared. Already the chemical
detection indicated a developmental change, since the non-acid
fraction of the newborn pig (Fig. 8(A), lane 1) had a major com-
pound migrating in the monoglycosylceramide region, and some
glycosphingolipids migrating as di- to tetra-glycosylceramides,
while the non-acid fraction of the adult pig intestine (Fig. 8(A), lane
2) was more complex, with a major compound in the triglyco-
sylceramide region, and also glycosphingolipids migrating as
penta- and hepta-glycosylceramides. The major triglycosylcer-
amide of porcine intestine is globotriaosylceramide [6], which is
not recognized by the F6 ﬁmbriae, and the complex glyco-
sphingolipids have terminal blood group H or A determinants [3].
Here several compounds recognized by monoclonal antibodies
directed against the blood group A determinant were present in the
non-acid fraction from adult pig intestine (Fig. 8(B), lane 2), while
the binding of the anti-A monoclonal antibodies to the non-acid
glycosphingolipids from the newborn pig intestine (Fig. 8(B), lane
1) was relatively weak. No binding of monoclonal antibodies
directed against the blood group H determinant to either fraction
was obtained (data not shown). The F6 ﬁmbriae again bound to a
compound migrating in the tetraglycosylceramide region in the
non-acid glycosphingolipids from the newborn pig intestine
(Fig. 8(C), lane 1).4. Discussion
In this study we identify two F6 ﬁmbriae binding glyco-
sphingolipids from piglet small intestinal mucosa. These F6-
binding compounds were characterized as lactotriaosylceramide
and lactotetraosylceramide. When screening a library of glyco-
sphingolipids, we found that the F6 ﬁmbriae also binds to the
related glycosphingolipids neolactotetraosylceramide, neo-
lactohexaosylceramide, and neolactooctaosylceramide. However,
the presence of neolacto glycoconjugates in the target tissue of F6-
ﬁmbriated E. coli has not been shown. In our series of studies of the
non-acid glycosphingolipids of mucosal scrapings of pig small in-
testine we have not found any glycosphingolipids with unsub-
stituted neolacto sequences [3,32,33]. Very little information about
the glycosylation of porcine intestinal glycoproteins is available.
However, the Galb4GlcNAc binding lectin from Erythrina cristagalli
did not bind to brush border membrane proteins from the small
intestine of newborn pigs [34], indicating an absence of unsub-
stituted neolacto sequences.
We have recently characterized the glycosphingolipid binding
speciﬁcities of F4ab, F4ac and F4ad ﬁmbriae of porcine entero-
toxigenic E. coli [6]. As shown in Table 2, the carbohydrate recog-
nition proﬁle of the F6 ﬁmbriae has features resembling all three
variants of F4 ﬁmbriae. The F4ad ﬁmbriae bound to neo-
lactotetraosylceramide, but this binding was occasional, in contrastto the high afﬁnity binding to lacto/neolacto sequences obtained
with the F6 ﬁmbriae.
Since the F6 ﬁmbriae bind to lactotriaosylceramide a terminal
GlcNAc is the minimal structural element required for binding to
occur. Terminal GlcNAc is also recognized by G ﬁmbria of human
uropathogenic E. coli, and by ﬁmbriae belonging to the F17 family
produced by bovine enterotoxigenic and invasive E. coli strains.
Crystal structures of the lectins domains of the G and F17 ﬁmbriae
in complex with N-acetylglucosamine have been reported [35,36].
However, the target cell receptors for these ﬁmbriae have not yet
been identiﬁed.
The F6 ﬁmbriae also binds to sulfatide, and Lysine-117 of the
FasG subunit has been identiﬁed as an important factor for the
interaction with sulfatide [17]. Interestingly, it was recently re-
ported that in the crystal complexes of the FimH, FedF and F17G
ﬁmbrial adhesins with their respective carbohydrate ligands, there
is in all three cases also highly charged regions in complex with
sulfate present in the vicinity of the reducing end sugars of the li-
gands in their carbohydrate binding sites [37]. High mutation rates
involving arginines and lysines was found in the two ETEC adhesins
(10 in 17 of the F17G, and 6 in 8 of the FedF lectin domains,
respectively), and it was speculated that this may be a functional
adaptation among ETEC strains allowing the bacteria to bind to
carbohydrate receptors that are increasingly modiﬁed with nega-
tive charges downstream the intestinal tract.
Dean et al. have reported that F6 ﬁmbriated E. coli colonize the
small intestine and cause diarrhea only in neonatal (<6-day-old)
piglets [38]. Still the F6 ﬁmbriated bacteria adhered in vitro to in-
testinal epithelial cells from both neonatal and weaned piglets, and
the same amounts of F6 binding galactosylceramide and sulfatide
was present in the glycosphingolipid preparations from the intes-
tinal epithelium of pigs of both ages. In addition they found gly-
cosphingolipids migrating as sulfatide and lactosylceramide in
Table 2
Comparison of glycosphingolipid binding of F4 ﬁmbriae and F6 ﬁmbriae.
No. Trivial name Structure F4aba F4ac F4ad F6 Source
Simple compounds
1. Galactosylceramide Galb1Cer þþþb þþþ  þ Porcine intestine
2. Sulfatide SO3-3Galb1Cer þþþ þ  þ Human intestine
3. LacCer Galb4Glcb1Cer þþþ þþþ þþþ þ Dog intestine
4. Lactotri GlcNAcb3Galb4Glcb1Cer    þþþ Human neutrophils
Ganglioseries
5. Gangliotri GalNAcb4Galb4Glcb1Cer   þþþ þ Guinea pig erythrocytes
6. Gangliotetra Galb3GalNAcb4Galb4Glcb1Cer   þþþ þ Mouse intestine
Neolactoseries
7. Neolactotetra Galb4GlcNAcb3Galb4Glcb1Cer   þ þþþ Human neutrophils
8. Neolactohexa Galb4GlcNAcb3Galb4GlcNAcb3Galb4Glcb1Cer NDc ND ND þþþ Rabbit thymus
9. Neolactoocta Galb4GlcNAcb3Galb4GlcNAcb3Galb4GlcNAcb3Galb4Glcb1Cer ND ND ND þþþ Rabbit thymus
Lactoseries
10. Lactotetra Galb3GlcNAcb3Galb4Glcb1Cer    þþþ Human meconium
Globoseries
11. Isoglobotri Gala3Galb4Glcb1Cer   þ þ Cat intestine
12. Globotri Gala4Galb4Glcb1Cer þþþ    Rat intestine
a Glycosphingolipid binding data for F4ab, F4ac, and F4ad ﬁmbriae are from ref [6].
b Binding is deﬁned as follows:þþþ denotes an intense and highly reproducible stainingwhen 4 mg of the glycosphingolipid was applied on the thin-layer chromatogram,þ
denotes an occasional staining, while  denotes no binding even at 4 mg.
c ND, not determined.
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of intestinal buffer washings on Sepharose CL-4B columns. There-
fore, it was proposed that receptors for F6 ﬁmbriated E. coli are
released into the intestinal mucus of older pigs, and there act as
decoys and prevents attachment to the intestinal epithelium [18].
However, the intestinal mucus gel contains mainly the very
large oligomeric glycoproteins known as mucins, and a number of
associated proteins [39,40]. The amphipathic glycosphingolipids,
on the other hand, are found in the cell membrane. Thus, the gly-
cosphingolipids found in the intestinal washings were break down
products either from extruded epithelial cells, or epithelial cells
extracted during the washing procedure.
The identiﬁcation of lactotriaosylceramide and lactote-
traosylceramide as F6 binding glycosphingolipids of piglet intestine
suggests an alternative explanation for the age-dependent diar-
rhea-inducing effect of F6-ﬁmbriated E. coli colonization of piglet
intestine. A developmental change of the acid glycosphingolipids of
pig intestine has previously been demonstrated [2,41], with very
simple composition in the intestine of the newborn pig, and more
complex gangliosides found in the adult pig intestine. The com-
parison of non-acid glycosphingolipids of newborn and adult pig
intestine shows that also the non-acid glycosphingolipids are more
complex in the adult pig. The majority of the complex non-acid
glycosphingolipids of adult pig intestine have blood group H and
A determinants on type 1 core chains, i.e. are built on lactote-
traosylceramide [3,32,33]. However, while lactotetraosylceramide
is readily recognized by the F6 ﬁmbriae, the aFuc in 2-position of
the terminal Gal of the blood group H type 1 determinant
(Fuca2Gal) blocks the F6 binding. Thus, the intestinal amounts of F6
binding lactotetraosylceramide will be reduced by the develop-
mental appearance of glycosphingolipids with blood group
determinants.
In summary, these studies implicate lactotriaosylceramide and
lactotetraosylceramide as candidate receptors for mediating
attachment of F6-ﬁmbriated enterotoxigenic E. coli to porcine small
intestinal cells. Our ﬁndingsmay be a basis for the rational design of
receptor saccharide analogs for inhibition of the intestinal adhesion
of F6-expressing E. coli.
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